July 13, 2017
Eli Lilly and Company reached a settlement in Virginia federal court with generic drug companies accused of infringing its unit-dose patent for its sexual dysfunction treatment Cialis, maintaining its market exclusivity until at least next fall, the company announced Wednesday.